Dr. Gilli Galore-Haskel, Ph.D.
VP of Research & Development
Dr. Gilli Galore-Haskel joined 4C Biomed in November 2016, upon its establishment. She brings extensive knowledge and experience in melanoma research and cancer immunotherapy. Prior to joining 4C Biomed, she served as Researcher and Project Manager at the Ella Lemelbaum Institute for Immuno-Oncology at Sheba Medical Center.
Gilli holds a B.Sc. in Life Sciences and M.Sc. in Human Genetics (with highest honors) and a Ph.D. in Clinical microbiology and Immunology focusing on melanoma immune resistance mechanisms, all from Tel Aviv University. She is the author of multiple peer-reviewed papers and has won several awards, including the EACR Travel Fellowship Award.